Metal radionuclide chelating compounds for improved chelation kinetics
AssigneeNeoRx Corporation
InventorsAnanthachari Srinivasan, Alan R. Fritzberg, David S. Jones
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeoRx Corporation
InventorsAnanthachari Srinivasan, Alan R. Fritzberg, David S. Jones
Estimating the term…
The present invention provides metal chelating compounds, to chelates and chelate-targeting agent conjugates formed from the chelating compounds, and to methods for making and using these compositions. The chelating compounds incorporate two nitrogen atoms and three sulfur atoms ("N.sub.2 S.sub.3 "), two nitrogen atoms and four sulfur atoms ("N.sub.2 S.sub.4 "), or three nitrogen atoms and three sulfur atoms ("N.sub.3 S.sub.3 "). Metals, and metal oxides, capable of being chelated by the compounds include those that are radionuclides, such as .sup.99m Tc and .sup.186/188 Re. The targeting agent portion of the chelate-targeting agent conjugates provided includes antibodies, peptides, hormones, enzymes and biological response modifiers. Methods for making the conjugates are provided and encompass the addition of a metal, or metal oxide, to a chelating compound prior to attachment to a targeting agent as well as subsequent to the attachment. Another aspect of the invention provides kits for producing chelate-targeting agent comjugates for radiopharmaceutical use. An additional aspect of the invention provides methods for using the chelate-targeting agent conjugates for diagnostic and therapeutic purposes, such as detection of a target site and delivery of a radionuclide to the site, respectively.
A metal chelate having the formula:
A chelate-targeting agent conjugate having the formula:
Dependencies are inferred from the claim text.